504 related articles for article (PubMed ID: 26001635)
21. Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials.
Kiltz U; van der Heijde D; Boonen A; Gensler LS; Gibble TH; Guo J; Carlier H; Braun J
J Rheumatol; 2023 Jun; 50(6):754-762. PubMed ID: 36725056
[TBL] [Abstract][Full Text] [Related]
22. Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial.
Sieper J; Landewé R; Rudwaleit M; van der Heijde D; Dougados M; Mease PJ; Braun J; Deodhar A; Kivitz A; Walsh J; Hoepken B; Nurminen T; Maksymowych WP
Arthritis Rheumatol; 2015 Mar; 67(3):668-77. PubMed ID: 25470228
[TBL] [Abstract][Full Text] [Related]
23. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
[TBL] [Abstract][Full Text] [Related]
24. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
Kilic G; Kilic E; Ozgocmen S
Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
[TBL] [Abstract][Full Text] [Related]
25. Validity and reliability of Work Productivity and Activity Impairment among patients with axial spondyloarthritis in Singapore.
Phang JK; Kwan YH; Fong W; Tan CS; Lui NL; Thumboo J; Leung YY
Int J Rheum Dis; 2020 Apr; 23(4):520-525. PubMed ID: 32020752
[TBL] [Abstract][Full Text] [Related]
26. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).
Robinson PC; Bird P; Lim I; Saad N; Schachna L; Taylor AL; Whittle SL; Brown MA
Int J Rheum Dis; 2014 Jun; 17(5):548-56. PubMed ID: 24673897
[TBL] [Abstract][Full Text] [Related]
27. Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
Rodrigues-Manica S; Silva J; Cruz-Machado R; Coelho C; Duarte J; Vieira-Sousa E; Tavares-Costa J; Pimentel-Santos FM
Clin Rheumatol; 2021 Jan; 40(1):33-41. PubMed ID: 32533340
[TBL] [Abstract][Full Text] [Related]
28. Instrumented BASFI (iBASFI) Shows Promising Reliability and Validity in the Assessment of Activity Limitations in Axial Spondyloarthritis.
Swinnen TW; Milosevic M; Van Huffel S; Dankaerts W; Westhovens R; de Vlam K
J Rheumatol; 2016 Aug; 43(8):1532-40. PubMed ID: 27307537
[TBL] [Abstract][Full Text] [Related]
29. ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.
van der Heijde D; Joshi A; Pangan AL; Chen N; Betts K; Mittal M; Bao Y
Rheumatology (Oxford); 2016 Jan; 55(1):80-8. PubMed ID: 26316575
[TBL] [Abstract][Full Text] [Related]
30. Validity and reliability of the Assessment of Spondyloarthritis International Society Health Index in English-speaking patients with axial spondyloarthritis in Singapore.
Kwan YH; Aw FF; Fong W; Phang JK; Kiltz U; Lim KK; Chew EH; Lui NL; Tan CS; Thumboo J; Østbye T; Leung YY
Int J Rheum Dis; 2019 Sep; 22(9):1644-1651. PubMed ID: 31245926
[TBL] [Abstract][Full Text] [Related]
31. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
Ørnbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindström U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomšič M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Østergaard M; Hetland ML
J Rheumatol; 2023 Aug; 50(8):1009-1019. PubMed ID: 36455943
[TBL] [Abstract][Full Text] [Related]
32. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.
Kiltz U; van der Heijde D; Boonen A; Akkoc N; Bautista-Molano W; Burgos-Vargas R; Wei JC; Chiowchanwisawakit P; Dougados M; Duruoz MT; Elzorkany BK; Gaydukova I; Gensler LS; Gilio M; Grazio S; Gu J; Inman RD; Kim TJ; Navarro-Compan V; Marzo-Ortega H; Ozgocmen S; Pimentel Dos Santos F; Schirmer M; Stebbings S; Van den Bosch FE; van Tubergen A; Braun J
Ann Rheum Dis; 2018 Sep; 77(9):1311-1317. PubMed ID: 29858176
[TBL] [Abstract][Full Text] [Related]
33. Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study.
Hwang MC; Martin M; Harris K; Geerdts P; Stark JL; Reveille J
Qual Life Res; 2020 Nov; 29(11):3155-3166. PubMed ID: 32607793
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
Burgos-Varga R; Wei JC; Rahman MU; Akkoc N; Haq SA; Hammoudeh M; Mahgoub E; Singh E; Llamado LJ; Shirazy K; Kotak S; Hammond C; Pedersen R; Shen Q; Vlahos B
Arthritis Res Ther; 2016 Jun; 18(1):132. PubMed ID: 27267875
[TBL] [Abstract][Full Text] [Related]
35. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
36. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness.
Haywood KL; M Garratt A; Jordan K; Dziedzic K; Dawes PT
Rheumatology (Oxford); 2002 Nov; 41(11):1295-302. PubMed ID: 12422003
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.
Wei JC; Wong RH; Huang JH; Yu CT; Chou CT; Jan MS; Tsay GJ; Chou MC; Lee HS
Clin Rheumatol; 2007 Oct; 26(10):1685-91. PubMed ID: 17286214
[TBL] [Abstract][Full Text] [Related]
38. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
[TBL] [Abstract][Full Text] [Related]
39. Validity and reliability of the Health Assessment Questionnaire among patients with spondyloarthritis in Singapore.
Kwan YH; Fong W; Lui NL; Yong ST; Cheung YB; Malhotra R; Thumboo J; Østbye T
Int J Rheum Dis; 2018 Mar; 21(3):699-704. PubMed ID: 27860306
[TBL] [Abstract][Full Text] [Related]
40. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
